The PhRMA Foundation recognizes the need to enhance diversity in clinical trials, and the use of digital health tools (DHT) also has the potential to support more equitable participation in medical research. Through this new program, the Foundation will invest in research on the use of DHTs in underrepresented populations in clinical trials to advance regulatory decision-making.

Funding

• Up to eight $25,000 planning grants: Awarded based on letters of intent (LOI) to support development of a detailed research proposal to submit to compete for the two larger grants
• Up to two $500,000 grants: Awarded to the top research proposals

Read more about these grants